News tagged with 'Cholesterol Drugs'

Merck and Schering-Plough agreed on Wednesday to pay $41.5 million to settle class-action lawsuits filed by patients taking the cholesterol drugs Vytorin and Zetia.

A review of several studies found that commonly used statin cholesterol drugs do not increase the risk of Lou Gehrig’s disease, according to the U.S. Food and Drug Administration.

The cholesterol drug Vytorin, sold by Merck & Schering-Plough, failed to meet the goal of improving outcomes any better than a placebo, according to a new study. The new data did little in the way of removing doubt from a previous study in January that suggested the combination drug failed to work any better than that of the cheaper generic statin. Vytorin did lower LDL cholesterol. More study is planned.

Researches wanted to determine if erectile dysfunction (ED) in diabetic men could be a trustworthy and independent warning sign that more severe health issues may be on the horizon. The answer in two published studies was yes. Those diabetics with ED were 58 percent more likely to have fatal heart disease or a heart attack or other non-fatal heart events. 

Vytorin, the cholesterol drug, had double the rate of artery clogging plaque formations as compared to taking Zocor alone. This was revealed in a study by the drug makers actually completed in 2006 but partially released today.

The Food and Drug Administration (FDA) today announced that Albers Medical Distributors, Inc., has voluntarily recalled three lots of 90-count bottles of the cholesterol-lowering drug Lipitor and is warning healthcare providers and others that these three lots of counterfeit Lipitor represent a potentially significant

Out-of-court Baycol settlements are on the rise despite Bayer Corporation's victories in the first two cases to go to trial. Bayer announced Wednesday that the pharmaceutical maker has settled 785 Baycol lawsuits (27 involving deaths from the drug) at a cost of $240 million. At the time of Bayer's successful first tr

Less than a month after Bayer Corporation was found not liable in the first lawsuit to go to trial over the cholesterol medication Baycol, a Mississippi court cleared the pharmaceutical maker in the second U.S. case to reach a jury. The lawsuit involved a woman in her 70s who alleged Baycol use led to debilitating m

A Corpus Christi, Texas jury Tuesday found Bayer Corporation not liable in the first lawsuit to go to trial over the cholesterol-lowering drug Baycol. The suit, filed by 82-year-old Hollis Haltom, was seeking $560 million in damages. During the trial, plaintiff attorneys argued that Baycol caused Haltom to develop

Jurors in Corpus Christi, Texas began deliberations Friday after hearing three weeks of testimony in the first lawsuit to go to trial over Bayer Corporation's withdrawn cholesterol drug Baycol. The plaintiff, 82-year-old retired engineer Hollis Haltom, alleges he began suffering from rhabdomyolysis , a severe muscle

Bayer Corporation stockholders, angered over the company's alleged misrepresentation of its withdrawn cholesterol drug Baycol, have filed a securities and investment fraud lawsuit against the pharmaceutical maker. In the claim, shareholders, seeking damages for the fall in the company's share price, allege Bayer viola

Lawyers arguing the first lawsuit to go to trial over the withdrawn cholesterol medication Baycol presented closing arguments Wednesday in Corpus Christi, Texas. Analysts have been keeping a close eye on the trial since it began last February, as many legal experts believe it may set a precedent for future Baycol li

A highly publicized trial involving the cholesterol-lowering drug Baycol continued in Corpus Christi, Texas this week with plaintiff attorneys presenting evidence that showed a mounting unease among Bayer executives even as they continued to market the controversial medication. According to memos and e-mails submitted

Plaintiff attorneys arguing the first lawsuit to go to trial over the withdrawn cholesterol drug Baycol are reportedly seeking $500 million in punitive damages. According to a German newspaper, the amount is in addition to compensation of around $100 million already demanded in the case. The suit , which is ong

Bayer Corporation's lead attorney announced Tuesday that the company was in talks to settle 500 lawsuits over its now-banned cholesterol medication Baycol. Bayer has already settled around 450 claims, at a cost of nearly $125 million. The additional 500 cases involve patients who now suffer from rhabdomyolysis , a s